<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02814448</url>
  </required_header>
  <id_info>
    <org_study_id>15-296</org_study_id>
    <secondary_id>UH2CA189883</secondary_id>
    <nct_id>NCT02814448</nct_id>
  </id_info>
  <brief_title>An Innovative Treatment for Cervical Pre Cancer</brief_title>
  <acronym>CryoPen</acronym>
  <official_title>CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Basic Health International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CryoPen, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Albert Einstein College of Medicine, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test two innovative devices, the CryoPen® and
      thermocoagulator, against gas-based cryotherapy to determine whether the novel devices
      produce equivalent or improved destruction of cervical tissue compared to gas-based
      cryotherapy. Tissue destruction with single freeze versus double freeze treatments with the
      CryoPen and gas-based cryotherapy will also be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of the study are to test the hypothesis that the CryoPen® and
      thermocoagulator provide a non-inferior depth of cervical tissue necrosis compared with
      traditional CO2-based cryotherapy and to test single versus double freeze applications. The
      secondary objectives of the study are to determine if the CryoPen® or thermocoagulator
      achieves a depth of necrosis of 3.5 mm, the accepted depth required for eradicating 95% of
      cervical precancer, and to observe the relationship between depth of necrosis and variations
      in cervical anatomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean depth of necrosis achieved with the LMIC-adapted CryoPen and the thermocoagulator compared to mean depth of necrosis achieved with CO2-based cryotherapy</measure>
    <time_frame>24-48 hours after treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean depth of necrosis achieved with a single freeze compared to mean depth of necrosis achieved with a double freeze</measure>
    <time_frame>24-48 hours after treatment</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Cervical Intraepithelial Neoplasia</condition>
  <arm_group>
    <arm_group_label>CO2 standard cryotherapy- double freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 standard cryotherapy- single freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single freeze treatment consists of one five-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CryoPen- double freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double freeze treatment consists of three-minute freeze, five-minute thaw, three-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CryoPen- single freeze</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single freeze treatment consists of one five-minute freeze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thermocoagulator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single heat application at 100 ºC for 40 seconds</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CryoPen</intervention_name>
    <description>Provides a means of freezing tissue without the use of gases or liquids</description>
    <arm_group_label>CryoPen- double freeze</arm_group_label>
    <arm_group_label>CryoPen- single freeze</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 standard cryotherapy</intervention_name>
    <description>Standard therapy using carbon dioxide for freezing of tissue</description>
    <arm_group_label>CO2 standard cryotherapy- double freeze</arm_group_label>
    <arm_group_label>CO2 standard cryotherapy- single freeze</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermocoagulator</intervention_name>
    <description>The use of heat produced by high-frequency electric current to bring about local destruction of tissues</description>
    <arm_group_label>Thermocoagulator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 25 and 65 years old.

          -  Scheduled for a hysterectomy for reasons other than cervical precancer or cancer

          -  Diagnosis of uterine, endometrial, ovarian or other cancer that does not jeopardize
             the tissue of the cervix is permitted

          -  Histological evaluation of the cervix does not interfere with the woman's current
             diagnosis

          -  Woman consents to participate after being informed about the study

          -  Normal Pap Smear or HPV test in the past 3 years

        Exclusion Criteria:

          -  Pregnancy

          -  History of cervical surgery in past 5 years

          -  Presence of cervical lesion pre-invasive or invasive on the cervix *

          -  Current Pelvic Inflammatory Disorder or severe acute cervicitis

          -  Cervix shape disfigured or hard to reach
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Cremer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital 1 de Mayo del Instituto Salvadoreño del Seguro Social</name>
      <address>
        <city>San Salvador</city>
        <country>El Salvador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Enfermedades Neoplásicas</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>El Salvador</country>
    <country>Peru</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 23, 2018</submitted>
    <returned>May 23, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

